By Emeritus Professor Allan David Spigelman

Journal articles

Talseth-Palmer BA; Holliday EG; Evans TJ; McEvoy M; Attia J; Grice DM; Masson AL; Meldrum C; Spigelman A; Scott RJ, 2013, 'Continuing difficulties in interpreting CNV data: Lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients', BMC Medical Genomics, 6, http://dx.doi.org/10.1186/1755-8794-6-10

Maringe C; Walters S; Rachet BP; Butler J; Fields T; Finan PJ; Maxwell R; Nedrebo BS; Pahlman LA; Sjovall A; Spigelman AD; Engholm G; Sjovall A; Gjerstorff ML; Hatcher J; Johannesen TB; Morris EJA; Mcgahan CE; Tracey E; Turner DJ; Richards MA; Coleman MP, 2013, 'Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000-2007', ACTA Oncologica, 52, pp. 919 - 932, http://dx.doi.org/10.3109/0284186X.2013.764008

Goldsbury D; Harris MF; Pascoe S; Barton MB; Olver I; Spigelman AD; Beilby J; Veitch C; Weller D; O Connell DL, 2013, 'The varying role of the GP in the pathway between colonoscopy and surgery for colorectal cancer: a retrospective cohort study', BMJ Open, 3, pp. 1 - 13, http://dx.doi.org/10.1136/bmjopen-2012-002325

Harris MF; Pascoe S; Crossland L; Beilby J; Veitch C; Spigelman A; Weller D, 2012, 'Patients with colorectal cancer A qualitative study of referral pathways and continuing care', Australian Family Physician, 41, pp. 899 - 902

Nieuwenhuis MH; Kets CM; Murphy-Ryan M; Colas C; Möller P; Hes FJ; Hodgson SV; Olderode-Berends MJW; Aretz S; Heinimann K; Gomez Garcia EB; Douglas F; Spigelman A; Timshel S; Lindor NM; Vasen HFA, 2012, 'Is colorectal surveillance indicated in patients with PTEN mutations?', Colorectal Disease, 14, http://dx.doi.org/10.1111/j.1463-1318.2012.03121.x

Reeves SG; Meldrum C; Groombridge C; Spigelman A; Suchy J; Kurzawski G; Lubinski J; Scott RJ, 2012, 'DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome', Cancer Epidemiology, 36, pp. 183 - 189, http://dx.doi.org/10.1016/j.canep.2011.09.003

Talseth-Palmer BA; Wijnen JT; Brenne IS; Jagmohan-Changur S; Ashton KA; Tops CM; Evans T-J; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman A; Møller P; Morreau HM; Van Wezel T; Lubinski J; Vasen HFA; Scott RJ, 2012, 'Chromosome 8q23.3, 10p14 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome – a combined analysis of the Australian, Dutch and Polish Lynch syndrome cohorts', Hereditary Cancer in Clinical Practice, 10, pp. A32 - A32, http://dx.doi.org/10.1186/1897-4287-10-s2-a32

Reeves S; Meldrum C; Groombridge C; Spigelman AD; Suchy J; Kurzawski G; Lubinski J; Scott RJ, 2012, 'DNA repair gene polymorphisms and risk of early onset colorectal cancer: findings from a qualitative study in general practice', Cancer Epidemiology, 36, pp. 183 - 189

Spigelman AD; Debono DS; Oates K; Dunn A; Braithwaite J, 2012, 'Patient safety teaching in Australian medical schools: a national survey', Clinical Risk, 18, pp. 46 - 51, http://cr.rsmjournals.com/content/18/2/46.full.pdf+html

Harris MF; Pascoe S; Crossland LJ; Beilby J; Veitch C; Spigelman AD; Weller D, 2012, 'Referral pathways and continuing care for patients with colorectal cancer: findings from a qualitative study in general practice', AUSTRALIAN FAMILY PHYSICIAN, 41, pp. 899 - 902

Goldsbury D; Harris MF; Pascoe S; Olver I; Barton M; Spigelman AD; O''connell D, 2012, 'Socio-demographic and other patient characteristics associated with time between colonoscopy and surgery, and choice of treatment centre for colorectal cancer: a retrospective cohort study', BMJ Open, 2, pp. e001070, http://dx.doi.org/10.1136/bmjopen-2012-001070

Zilliacus EM; Meiser B; Lobb EA; Kelly P; Barlow-Stewart K; Kirk J; Spigelman AD; Warwick L; Tucker K, 2011, 'Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast/ovarian cancer genetic counseling?', Genetics in Medicine, 13, pp. 933 - 941

Vilain R; Dudding T; Braye S; Groombridge C; Meldrum C; Spigelman AD; Ackland S; Ashman L; Scott R, 2011, 'Can a familial gastrointestinal tumour syndrome be allelic with Waardenberg Syndrome?', Clinical Genetics: an international journal of genetics and molecular medicine, 79, pp. 1 - 7, http://dx.doi.org/10.1111/j.1399-0004.2010.01489.x

Spigelman AD, 2011, 'Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007: the international cancer benchmarking partnership', Lancet, 377, pp. 127 - 138, http://dx.doi.org/10.1016/S0140

Travaglia JF; Debono DS; Spigelman AD; Braithwaite J, 2011, 'Clinical governance: a review of key concepts in the literature', Clinical Governance: an International Journal, 16, pp. 62 - 77, http://dx.doi.org/10.1108/14777271111104592

Talseth-Palmer B; Brenne I; Ashton K; Evans T; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman AD; Lubinski J; Scott R, 2011, 'Colorectal cancer susceptibility Ioci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome', Journal of Medical Genetics, 48, pp. 279 - 284, http://dx.doi.org/10.1136/jmg.2010.079962

Spigelman AD, 2011, 'Long term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial', Lancet, 378, pp. 2081 - 2087, http://dx.doi.org/10.1016/S0140

Spigelman AD, 2011, 'New Governments: New policies', Clinical Governance: an International Journal, 16, pp. 250 - 251, http://dx.doi.org/10.1108/14777271111170607

Harris MF; Pascoe S; Crossland LJ; Beilby J; Veitch C; Spigelman AD, 2011, 'Referral pathways in colorectal cancer: findings from a qualitative study in general practice', Medical Journal of Australia, 195, pp. 178 - 179

Mitra AV; Bancroft EK; Barbachano Y; Page EC; Foster C; Jameson CF; Mitchell G; Lindeman GJ; Stapleton AM; Suthers G; Evans D; Cruger DG; Blanco I; Mercer CL; Kirk J; Maehle LO; Hodgson S; Walker L; Izatt L; Douglas F; Tucker K; Dorkins H; Clowes VE; Male AM; Donaldson A; Brewer C; Doherty R; Bulman B; Osther PJS; Salinas M; Eccles DM; Axcrona K; Jobson I; Newcombe B; Cybulski C; Rubinstein WS; Buys S; Townshend S; Friedman E; Domchek SM; Ramon y cajal T; Spigelman AD; Teo SH; Nicolai N; Aaronson NK; Ardern-jones AT; Bangma CH; Dearnaley DP; Eyfjord JE; Falconer AD; Gronberg ; Hamdy FC; Johannsson OT; Khoo VS; Kote-jarai Z; Lilja H; Lubinski J; Melia J; Moynihan C; Peock S; Rennert G; Schroder F; Sibley PEC; Suri M; Wilson P; Bignon YJ; Strom S; Tischkowitz MD; Liljegren A; Ilencikova D; Abeles A; Kyriacou K; Van asperen CJ; Kiemeney LALM; Easton D; Eeles RA, 2011, 'Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: Preliminary analysis of the results of the IMPACT study', British Journal of Urology International, 107, pp. 28 - 39, http://dx.doi.org/10.1111/j.1464-410X.2010.09648.x

Spigelman AD, 2010, 'Australian Perspectives: Health System Reform', Clinical Governance: an International Journal, 15, pp. 46 - 49

Talseth-Palmer B; McPhillips M; Groombridge C; Spigelman AD; Scott R, 2010, 'MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer', Hereditary Cancer in Clinical Practice, 8, pp. 1 - 10, http://dx.doi.org/10.1186/1897-4287-8-5

Frydoonfar H; McGrath D; Hunt JA; Dunkley C; Spigelman AD, 2010, 'Serum Glutathione transferase does not respond to Indole-3-carbinol: a pilot study', Therapeutics and Clinical Risk Management, 2010, pp. 225 - 231

Kable A; Gibberd R; Spigelman AD, 2009, 'Adverse events in five surgical procedures', Clinical Governance: an International Journal, 14, pp. 145 - 155

Spigelman AD, 2009, 'Clinical outcome information: the patient patient', Clinical Governance: an International Journal, 14, pp. 245 - 247

Latchford A; Neale K; Spigelman AD; Phillips R; Clark S, 2009, 'Features of Duodenal Cancer in Patients With Familial Adenomatous Polyposis', Clinical Gastroenterology and Hepatology, 7, pp. 659 - 663

Johnstone D; Talseth-Palmer B; Evans T; Spigelman AD; Groombridge C; Milward EA; Olynyk JK; Suchy J; Kurzawski G; Lubinski J; Scott R, 2009, 'Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age', International Journal of Cancer, 125, pp. 78 - 83

Mireskandari S; Angster J; Meiser B; Thewes B; Groombridge C; Spigelman AD; Andrews L, 2009, 'Impact of familial adenomatous polyposis (FAP) on young adults: A qualitative study', Journal of Genetic Counseling, 18, pp. 409 - 417

Reeves S; Meldrum C; Groombridge C; Spigelman AD; Suchy J; Kurzawski G; Lubinski J; McElduff S; Scott R, 2009, 'MTHFR 677 C>T and 1298 A>C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer', European Journal of Human Genetics, 17, pp. 629 - 635

Wolfenden L; Wiggers J; Campbell E; Knight J; Kerridge RK; Spigelman AD, 2009, 'Providing comprehensive smoking cessation care to surgical patients: The case for computers', Drug and Alcohol Review, 28, pp. 60 - 65

Spigelman AD, 2008, 'Clinical governance units in New South Wales, Australia', Clinical Governance: An International Journal, 13, pp. 15 - 21, http://dx.doi.org/10.1108/cgij.2008.24813cab.002

Aittomäki K; Spigelman A; Weber W; Zajac V, 2008, 'Other short opinions/comments on moderate/low cancer genetic risk markers in medical practice and the article Genetic contribution to all cancers: The first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology by Lubinski et al., Breast Cancer Res Treat 2008 Apr 15', Hereditary Cancer in Clinical Practice, 6, pp. 67 - 68

Zilliacus E; Meiser B; Lobb E; Kirk J; Spigelman A; Barlow-Stewart K; Warwick L; Tucker K, 2008, 'A balancing act - Practitioners' experiences of telehealth cancer genetic counselling', PSYCHO-ONCOLOGY, 17, pp. S157 - S158, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257874200297&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McGrath DR; Spigelman AD, 2008, 'Putative mechanisms of action for indole-3-carbinol in the prevention of colorectal cancer', Expert Opinion on Therapeutic Targets, 12, pp. 729 - 738, http://dx.doi.org/10.1517/14728222.12.6.729

Spigelman AD, 2008, 'Déjà vu 4 U', Clinical Governance, 13, pp. 147 - 148, http://dx.doi.org/10.1108/14777270810867357

Wakefield CE; Meiser B; Homewood J; Peate ML; Taylor A; Lobb EA; Kirk J; Young M; Williams R; Dudding T; Tucker K, 2008, 'A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk', Breast Cancer Research and Treatment, 107, pp. 289 - 301, http://dx.doi.org/10.1007/s10549-007-9539-2

Wakefield CE; Meiser B; Homewood J; Taylor A; Gleeson MA; Williams R; Tucker K; Ward RL, 2008, 'A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling', Psycho - Oncology, 17, pp. 844 - 854

Spigelman AD, 2008, 'Australian Perspectives: Clinical governance units in New South Wales, Australia', Clinical Governance: an International Journal, 13, pp. 225 - 226

Spigelman AD, 2008, 'Australian Perspectives: Deja vu 4 U', Clinical Governance: an International Journal, 13, pp. 147 - 148

Spigelman AD, 2008, 'Erratum: Pathology reporting of resected colorectal cancers in New South Wales in 2000 (vol 77, pg 963, 2007)', Australian and New Zealand Journal of Surgery, 78, pp. 112 - 112, http://dx.doi.org/10.1111/j.1445-2197.2007.04420.x

Wolfenden L; Wiggers J; Campbell E; Knight J; Kerridge RK; Moore CH; Spigelman AD; Harrison MJ, 2008, 'Feasibility, acceptability, and cost of referring surgical patients for postdischarge cessation support from a quitline', Nicotine and Tobacco Research, 10, pp. 1105 - 1108

Brand CL; Tropea J; Ibrahim JE; Elkadi S; Bain CJ; Ben-Tovim D; Bucknall T; Greenberg P; Spigelman AD, 2008, 'Measurement for improvement: a survey of current practice in Australian public hospitals', Medical Journal of Australia, 189, pp. 35 - 40

Kable A; Gibberd R; Spigelman AD, 2008, 'Measuring compliance with surgical antibotic protocols: an intervention', Clinical Governance: an International Journal, 13, pp. 296 - 304

Aittomaki K; Spigelman AD; Weber W; Zajac V, 2008, 'Other short opinions/comments on moderate/low cancer genetic risk markers in medical practice and the article Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis a', Hereditary Cancer in Clinical Practice, 6, pp. 67 - 68

Kable A; Gibberd R; Spigelman AD, 2008, 'Predictors of adverse events in surgical admissions in Australia', International Journal for Quality in Health Care, 20, pp. 406 - 411

McGrath D; Spigelman AD, 2008, 'Putative mechanisms of action for indole-3-carbinol in the prevention of colorectal cancer', Expert Opinion on Therapeutic Targets, 12, pp. 729 - 738, http://dx.doi.org/10.1517/14728220802097748

Wakefield CE; Meiser B; Homewood J; Ward RL; O Donnell S; Kirk J, 2008, 'Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk', Cancer, 113, pp. 956 - 965

Mcgrath DR; Frydoonfar HR; Hunt JJ; Dunkley CJ; Spigelman AD, 2007, 'Potential mechanisms for the chemoprotective effect of cruciferous vegetables in colo-rectal cancer: a clinical trial of indole-3-carbinol', PROCEEDINGS OF THE NUTRITION SOCIETY, 66, pp. 38A - 38A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000252590100068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Young JM; Leong D; Armstrong K; O Connell DL; Armstrong BK; Spigelman AD; Ackland S; Chapuis P; Kneebone AB; Solomon MJ, 2007, 'Concordance with national guidelines for colorectal cancer care in New South Wales: a population-based patterns of care study', Medical Journal of Australia, 186, pp. 292 - 295

Groombridge C; Burgess B; Spigelman AD; O Toole L, 2007, 'Disseminating risk information to familial adenomatous polyposis families', Familial Cancer, 6, pp. 323 - 324

Back to profile page